Abstract
dc:description.abstractAtrial fibrillation (AF) is the most common cardiac arrhythmia, and its presence is associated with higher risk of adverse outcomes such as stroke, heart failure, and mortality. Increases in the prevalence of this condition have outpaced projections, underscoring the importance of identifying and controlling AF risk factors. In this dissertation, we investigated diverse, broadly relevant factors that may impact the risk of AF. Manuscript 1 comprised a series of 3 emulated clinical trials assessing the comparative effectiveness of tirzepatide, semaglutide, and SGLT2 inhibitors in the MarketScan administrative claims databases. In head-to-head comparisons, we evaluated the associations of new use of these drugs in patients with type 2 diabetes and the incidence of 4 arrhythmia subtypes. Both tirzepatide and semaglutide use were associated with lower risk of arrhythmias compared with SGLT2 inhibitors, and we detected no difference in risk in comparisons of tirzepatide and semaglutide. Manuscript 2 investigated the relationship between chronic air pollution exposure and incident AF in the MESA study. State-of-the-art methods were employed to estimate time-varying, residence-specific exposure to 4 pollutants (PM₂.₅, NO₂, NOₓ, and O₃) over 17 years median follow-up. For each pollutant, associations were directionally consistent with higher risk of AF, though only for NO₂ were results statistically significant. Manuscript 3 examined the strength of association between measures of biological aging and the development of AF in the ARIC study. We calculated values of age acceleration based on 2 epigenetic clocks (GrimAge and PhenoAge) and 2 proteomic clocks (created by Oh et al and Sathyan et al). Age acceleration according to each clock was associated with higher risk of incident AF. Associations were numerically strongest for GrimAge, followed by the 2 proteomic clocks and then PhenoAge. Together, these manuscripts provide valuable evidence elucidating the potential role of pharmaceutical, environmental, and biological factors in modifying AF risk.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Cannon, Ethan J.
Subjects
dc:subject × 6Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Citation
- Cannon, Ethan J.. (2026). Risk Factors and Prevention of Atrial Fibrillation. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/283065.